| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.067 | 0.7 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.066 | 0.7 |